Skip to content
Amwill Health Care logo

Amwill Health Care

544353 BSE
₹41.82

Close ·

P/E
0.14
View as Markdown
MCP
Close 4 Nov 2026 ₹41.82 −12.18 −22.6% 1Y
Start ₹54.00

Key Fundamentals

SMEPharmaceuticals & BiotechnologyHealthcare

Price-based figures at the close · TTM

ROCE
20.50%
Debt to Equity
0.00
EPS (TTM)
₹299.20
Book Value
₹40.28
Market Cap
—
P/E (TTM)
0.14
P/B
1.04
ROE
15.30%
Dividend Yield
1.19%
EBITDA
₹15.90 Cr
52W High
₹57.00
52W Low
₹28.91

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

69 Strong

Data confidence 95/100

Category scores

Quality
75
Strong
Returns, margins, earnings quality 22% weight
Valuation
70
Strong
Cheap vs sector & own history 24% weight
Growth
60
Good
Sales & profit trajectory 9% weight
Financial Health
86
Strong
Solvency, leverage, coverage 9% weight
Momentum
76
Strong
Trend strength, vol-adjusted 12% weight
Ownership
58
Good
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

4
  • Company is almost debt free.
  • Stock is trading at 1.07 times its book value
  • Company has delivered good profit growth of 68.1% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 26.9%

Weaknesses

1
  • Company has high debtors of 177 days.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1171
OscillatorsBearish270
Moving AveragesStrong Bearish901

Key readings

RSI (14)
45.22
Neutral
MACD (12,26,9)
−0.39
Bearish
SMA (50)
43.26
Bearish
SMA (200)
39.67
Bullish

As of

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
5Y+20.39%
3Y+15.37%
1Y+16.22%

Net profit

Net profit growth by window
5YTurned to profit
3Y+54.20%
1Y0.00%

Operating cash flow

Operating cash flow growth by window
5YZero base
3Y+16.96%
1Y+33.33%

Operating margin· change in pp

Operating margin growth by window
5Y+36.11 pp
3Y+15.94 pp
1Y−2.20 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2021₹17.00 Cr
Mar 2022₹26.00 Cr
Mar 2023₹28.00 Cr
Mar 2024₹42.00 Cr
Mar 2025₹37.00 Cr
Mar 2026₹43.00 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2021−₹1.00 Cr
Mar 2022₹3.00 Cr
Mar 2023₹3.00 Cr
Mar 2024₹12.00 Cr
Mar 2025₹11.00 Cr
Mar 2026₹11.00 Cr

Half-yearly Results

₹ Cr
544353 half-yearly results, ₹ crore
Particulars Sep 2024Mar 2025Sep 2025Mar 2026
Sales
23
17
21
24
Expenses
14
15
17
15
Operating Profit
9
3
4
9
OPM %
38%
16%
19%
37%
Other Income
0
1
1
2
Interest
0
0
0
0
Depreciation
0
0
0
0
PBT
9
3
5
10
Tax %
26%
−34%
26%
25%
Net Profit
7
4
4
8
EPS (₹)
4.18
2.1
1.93
3.77

Profit & Loss

₹ Cr
544353 profit and loss, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
17
26
28
42
37
43
Expenses
18
22
24
25
26
30
Operating Profit
−1
4
4
17
12
13
OPM %
−6%
14%
15%
40%
31%
30%
Other Income
0
0
0
0
1
3
Interest
0
0
0
0
0
0
Depreciation
0
0
0
0
0
1
PBT
−1
3
4
17
12
15
Tax %
−3%
23%
25%
25%
10%
26%
Net Profit
−1
3
3
12
11
11
EPS (₹)
−1.06
2.73
3.31
8.01
5.36
5.71
Div. Payout %
0%
0%
0%
0%
0%
9%

Balance Sheet

₹ Cr
544353 balance sheet, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.03
0.03
0.03
0.05
20
20
Reserves
−1
1
5
17
49
61
Borrowings
0
0
0
0
0
0
Other Liabilities
9
5
8
2
2
6
Total Liabilities
8
7
12
19
71
87
Fixed Assets
1
0
1
1
1
1
CWIP
0
0
0
1
0
0
Investments
0
0
0
0
0
3
Other Assets
7
6
12
18
70
83
Total Assets
8
7
12
19
71
87

Cash Flow

₹ Cr
544353 cash flow, annual, ₹ crore
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
3
5
−3
6
8
Investing
−1
0
−1
−1
−46
6
Financing
0
0
0
0
41
0
Net Cash Flow
−1
3
3
−4
1
14
Free Cash Flow
−1
3
4
−4
5
7
CFO/EBITDA
−26
108
135
6
62
88

Ratios

544353 financial ratios, annual
Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
93
12
16
114
163
177
Inventory Days
—
—
—
66
—
—
Days Payable
—
—
—
39
—
—
Cash Conversion Cycle
93
12
16
141
163
177
Working Capital Days
−45
−25
−38
111
166
158
ROCE %
—
1069%
133%
153%
28%
21%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Amwill Health Care insights

50 extracted metrics across FY21–FY26.

Shareholding Pattern

As of Sep 2026

  • Promoters 70.65%
  • Public 26.71%
  • Others 2.16%
  • DIIs 0.48%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Amwill Health Care

What does Amwill Health Care Ltd do?
Incorporated in 2009, Amwill Health Care is in the wholesale trading of pharmaceutical products
Where is Amwill Health Care Ltd (AMWILL) listed?
Amwill Health Care Ltd trades under code 544353 on the BSE.
Which sector does Amwill Health Care Ltd belong to?
Amwill Health Care Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the PE ratio of Amwill Health Care Ltd?
Amwill Health Care Ltd trades at a PE ratio of 0.14 as of 4 Nov 2026, on earnings per share of ₹299.2, against a book value of ₹40.28 per share.
What is the 52-week high and low of Amwill Health Care Ltd?
Over the last 52 weeks Amwill Health Care Ltd has traded between ₹28.91 and ₹57 as of 4 Nov 2026.
Does Amwill Health Care Ltd pay dividends?
Amwill Health Care Ltd has a dividend yield of 1.19%.
What is the Return on Equity (ROE) of Amwill Health Care Ltd?
Amwill Health Care Ltd reported a return on equity of 15.30%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 2009, Amwill Health Care is in the wholesale trading of pharmaceutical products

Website amwillhealthcare.com
Listed 12 Feb 2025
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544353.md for Amwill Health Care Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month